Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login

Linagliptin Vs. Januvia

Share Post:

What is Linagliptin?

It is an oral diabetes medication that is used to control high amounts of blood sugar in type 2 diabetic patients. Linagliptin, which is the generic name for Tradjenta, works by increasing hormones in the pancreas to produce more insulin. This helps to reduce high levels of blood sugar. This drug should be taken regularly. To remember your daily dose, you can take linagliptin at the same time every day.

What is Januvia?

It is a diabetes drug that regulates insulin levels. Insulin is a hormone that works in the body by managing blood glucose levels. Januvia, which is also known as sitagliptin, can be used alone or in combination with other oral diabetes drugs. However, this medication should not be used to treat type 1 diabetic people. Januvia does not usually result in low blood sugar in diabetic patients, but it may cause hypoglycemia if it is taken with sulfonylureas. This medication is usually prescribed together with exercise and diet. Take this drug exactly as it is prescribed by your health-care provider.

Similarities and differences between Januvia vs. Linagliptin

Similarities

Linagliptin and Januvia belong to a class of diabetes drugs known as dipeptidyl peptidase 4 (DPP-4) inhibitors. Drugs in this class work by inhibiting the action of an enzyme called DPP-4 that destroys the substances needed to lower blood sugar. Incretin regulates blood glucose levels by producing more insulin when it is needed by the body, and reducing the amount of glucose that is secreted by liver when the body does not need it. Another similarity is that both medications are available in a pill form. You can take linagliptin or Januvia with meals or without. When it comes to side effects, both drugs usually cause hypoglycemia and weight gain. Both medicines are prescription drugs used to treat patients who have type 2 diabetes. Type 2 diabetes refers to a condition where the body does not effectively use insulin.

Differences

There is a difference between linagliptin and Januvia in terms of strength dose. Linagliptin is available in 1 dose strength of 5mg, while Januvia comes in 3 dose options of 25mg, 50mg and 100mg. Your doctor will determine the dosage that you should take. Januvia is the brand name of sitagliptin, while Tradjenta is the brand name of linagliptin.

Doctor’s Recommendation

Research shows that linagliptin and sitagliptin are equally effective. The choice between these two medications depends on their availability and cost. While both work the same, linagliptin is a better option for patients with kidney problems since it can be used safely by those with kidney issues. Therefore, it should be made available in the Iranian market alongside sitagliptin, allowing doctors to choose the best option for patients with different health conditions.

Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.

Medically Reviewed

Profile image of Lalaine Cheng

Medically Reviewed By Lalaine ChengA dedicated medical practitioner with a Master’s degree in Public Health, specializing in epidemiology with a profound focus on overall wellness and health, brings a unique blend of clinical expertise and research acumen to the forefront of healthcare. As a researcher deeply involved in clinical trials, I ensure that every new medication or product satisfies the highest safety standards, giving you peace of mind, individuals and healthcare providers alike. Currently pursuing a Ph.D. in Biology, my commitment to advancing medical science and improving patient outcomes is unwavering.

Profile image of CDI Staff Writer

Written by CDI Staff WriterOur internal team are experts in many subjects. on March 14, 2022

Related Articles

Diabetes, Diabetes Supplies,
Geographical Analysis of Diabetes Prevalence and Insulin Demand in the U.S.

Diabetes has become a major public health challenge in the United States, affecting millions of individuals across all regions. The disease’s prevalence varies significantly by state, influenced by lifestyle, genetics,…

Read More
Diabetes, Diabetes Supplies,
Understanding Insulin Pricing: A State-by-State Comparison in the U.S.

The cost of insulin remains a critical concern for many Americans living with diabetes. Insulin pricing varies significantly across states, influenced by factors like healthcare policies, insurance coverage, and local…

Read More
Diabetes, Diabetes Supplies,
Mapping Insulin Accessibility in Major U.S. Cities: Bridging the Gaps

The rise in diabetes cases across urban areas has turned insulin accessibility into a pressing public health issue. While major U.S. cities are often considered hubs of advanced healthcare systems,…

Read More
Diabetes, Insulin
Common and Rare Lantus Side Effects: What to Expect

Summary: Lantus, a long-acting insulin, helps manage blood sugar levels in people with diabetes. While generally safe, it may cause common side effects such as low blood sugar and injection…

Read More